Experts in strategy + advanced analytics for pharmaceutical market access.

Market access success begins with strategy informed by strong scientific evidence.

Health technology assessment + strategy

Evidence synthesis + advanced analytics

Real-world evidence generation + analytics

Decision analytics + economic evaluation

Our cloud-based platform analyzes 5000+ reimbursement reports and provides customized interactive dashboards to help inform your HTA strategy.

012345678900123456789001234567890                     +
Years of senior experience
012345678900123456789001234567890                     +
Health technology assessments (CADTH, NICE, SMC, NCPE, IQWiG, NoMA, HAS, PBAC, ICER…)
012345678900123456789001234567890                     +
Peer-reviewed scientific publications
012345678900123456789001234567890                     +
Therapeutic indications
“An important strategic partner in reimbursement. Methodologists who understand the industry exceptionally well.”
⎻ DirectorHEOR, small biotech
"I have worked with the founders at Pharmalytics Group for more than a decade. They are a strategic, powerful team at the height of their careers. Always a pleasure to work with.”
⎻ Vice President, Medical Affairs, top 5 pharma company
“Pharmalytics Group provides scientifically rigorous, high-quality research in a timely manner. The team is friendly and courteous. I highly recommend them to my colleagues working in HEOR and reimbursement.”
⎻ Executive Director, HEOR, top 5 pharma company
“Pharmalytics Group provided us with a strategic roadmap to seek reimbursement in several countries. They provided us with all the supporting scientific services and educated us on methods behind the analyses performed. Their expertise and guidance was greatly appreciated. We will be sure to work with them again on our next indication.”
⎻ Vice President, Market Access, small biotech